Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16410367rdf:typepubmed:Citationlld:pubmed
pubmed-article:16410367lifeskim:mentionsumls-concept:C0035126lld:lifeskim
pubmed-article:16410367lifeskim:mentionsumls-concept:C0040648lld:lifeskim
pubmed-article:16410367lifeskim:mentionsumls-concept:C0063700lld:lifeskim
pubmed-article:16410367lifeskim:mentionsumls-concept:C0151763lld:lifeskim
pubmed-article:16410367lifeskim:mentionsumls-concept:C0086597lld:lifeskim
pubmed-article:16410367pubmed:issue6lld:pubmed
pubmed-article:16410367pubmed:dateCreated2006-5-11lld:pubmed
pubmed-article:16410367pubmed:abstractTextHepatic ischemia occurs in the settings of trauma, transplantation, and elective liver resections. The initiating events that account for local organ damage are only partially understood. Interferon (IFN) regulatory factor-1 (IRF-1) is a transcription factor that regulates the expression of a number of genes involved in both innate and acquired immunity; however, its function in liver injury is unknown. Therefore, the purpose of this study was to investigate the role of IRF-1 in hepatic ischemia-reperfusion (I/R) injury. In C57BL/6 mice undergoing 60 min of hepatic ischemia, IRF-1 protein expression increased as early as 1 h after reperfusion. IRF-1 knockout mice were significantly protected from hepatic I/R-induced damage compared with their wild-type controls. Hepatic I/R injury resulted in marked activation of the MAP kinase c-Jun NH(2)-terminal kinase (JNK) in wild-type mice but not IRF-1 knockout mice. IRF-1 knockout mice also exhibited significantly lower hepatic expression of TNF-alpha, IL-6, ICAM-1, and inducible nitric oxide synthase (iNOS) mRNA. Adenoviral delivery of IRF-1 into C57BL/6 mice resulted in increased liver damage even without an ischemic insult. This injury was associated with increased JNK activation and hepatic iNOS expression. Because IRF-1 contributed to liver injury, we also examined for inflammatory signals that regulated IRF-1 gene expression in cultured hepatocytes. Whereas IFN-gamma and IFN-beta were strong inducers of IRF-1 mRNA (>10-fold) in a time- and dose-dependent manner, TNF-alpha and IL-1beta also induced IRF-1 mRNA to a lesser extent (2- to 3-fold). IL-6 and lipopolysaccharide had no effect on IRF-1 expression. This study demonstrates that IRF-1 exerts a harmful role in hepatic I/R injury by modulating the expression of multiple inflammatory mediators. We further show that IRF-1-mediated injury involves the activation of JNK and that hepatocellular IRF-1 expression itself is regulated by specific cytokines.lld:pubmed
pubmed-article:16410367pubmed:languageenglld:pubmed
pubmed-article:16410367pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16410367pubmed:citationSubsetIMlld:pubmed
pubmed-article:16410367pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16410367pubmed:statusMEDLINElld:pubmed
pubmed-article:16410367pubmed:monthJunlld:pubmed
pubmed-article:16410367pubmed:issn0193-1857lld:pubmed
pubmed-article:16410367pubmed:authorpubmed-author:GellerDavid...lld:pubmed
pubmed-article:16410367pubmed:authorpubmed-author:IzuishiKunihi...lld:pubmed
pubmed-article:16410367pubmed:authorpubmed-author:IkedaAtsushiAlld:pubmed
pubmed-article:16410367pubmed:authorpubmed-author:NakaoAtsunori...lld:pubmed
pubmed-article:16410367pubmed:authorpubmed-author:YimJohn HJHlld:pubmed
pubmed-article:16410367pubmed:authorpubmed-author:TsungAllanAlld:pubmed
pubmed-article:16410367pubmed:authorpubmed-author:StangMichael...lld:pubmed
pubmed-article:16410367pubmed:authorpubmed-author:JeyabalanGeet...lld:pubmed
pubmed-article:16410367pubmed:authorpubmed-author:CritchlowNath...lld:pubmed
pubmed-article:16410367pubmed:authorpubmed-author:ChanMeagan...lld:pubmed
pubmed-article:16410367pubmed:issnTypePrintlld:pubmed
pubmed-article:16410367pubmed:volume290lld:pubmed
pubmed-article:16410367pubmed:ownerNLMlld:pubmed
pubmed-article:16410367pubmed:authorsCompleteYlld:pubmed
pubmed-article:16410367pubmed:paginationG1261-8lld:pubmed
pubmed-article:16410367pubmed:meshHeadingpubmed-meshheading:16410367...lld:pubmed
pubmed-article:16410367pubmed:meshHeadingpubmed-meshheading:16410367...lld:pubmed
pubmed-article:16410367pubmed:meshHeadingpubmed-meshheading:16410367...lld:pubmed
pubmed-article:16410367pubmed:meshHeadingpubmed-meshheading:16410367...lld:pubmed
pubmed-article:16410367pubmed:meshHeadingpubmed-meshheading:16410367...lld:pubmed
pubmed-article:16410367pubmed:meshHeadingpubmed-meshheading:16410367...lld:pubmed
pubmed-article:16410367pubmed:meshHeadingpubmed-meshheading:16410367...lld:pubmed
pubmed-article:16410367pubmed:meshHeadingpubmed-meshheading:16410367...lld:pubmed
pubmed-article:16410367pubmed:meshHeadingpubmed-meshheading:16410367...lld:pubmed
pubmed-article:16410367pubmed:meshHeadingpubmed-meshheading:16410367...lld:pubmed
pubmed-article:16410367pubmed:year2006lld:pubmed
pubmed-article:16410367pubmed:articleTitleThe transcription factor interferon regulatory factor-1 mediates liver damage during ischemia-reperfusion injury.lld:pubmed
pubmed-article:16410367pubmed:affiliationDepartment of Surgery, University of Pittsburgh, PA 15213, USA.lld:pubmed
pubmed-article:16410367pubmed:publicationTypeJournal Articlelld:pubmed
entrez-gene:16362entrezgene:pubmedpubmed-article:16410367lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:16410367lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16410367lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16410367lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16410367lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16410367lld:pubmed